Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Monitoring Direct Oral Anticoagulants: Longing for the Days When We Were in Control?

Pollak PT, Mitchell LB.

Can J Cardiol. 2019 Jun;35(6):694-698. doi: 10.1016/j.cjca.2019.04.009. Epub 2019 Apr 18. No abstract available.

PMID:
31151700
2.

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.

Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL; CABANA Investigators.

JAMA. 2019 Mar 15. doi: 10.1001/jama.2019.0693. [Epub ahead of print]

PMID:
30874766
3.

Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation.

Lee H, Tan MK, Yan AT, Angaran P, Dorian P, Bucci C, Gregoire JC, Bell AD, Green MS, Gross PL, Skanes A, Kerr CR, Mitchell LB, Cox JL, Essebag V, Heilbron B, Ramanathan K, Fournier C, Wheeler BH, Lin PJ, Berall M, Langer A, Goldin L, Goodman SG; FREEDOM AF and CONNECT AF Investigators.

Can J Cardiol. 2019 Feb;35(2):160-168. doi: 10.1016/j.cjca.2018.11.023. Epub 2018 Dec 3.

PMID:
30760422
4.

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.

Andrade JG, Verma A, Mitchell LB, Parkash R, Leblanc K, Atzema C, Healey JS, Bell A, Cairns J, Connolly S, Cox J, Dorian P, Gladstone D, McMurtry MS, Nair GM, Pilote L, Sarrazin JF, Sharma M, Skanes A, Talajic M, Tsang T, Verma S, Wyse DG, Nattel S, Macle L; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2018 Nov;34(11):1371-1392. doi: 10.1016/j.cjca.2018.08.026.

PMID:
30404743
5.

Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.

Zareba W, Daubert JP, Beck CA, Huang DT, Alexis JD, Brown MW, Pyykkonen K, McNitt S, Oakes D, Feng C, Aktas MK, Ayala-Parades F, Baranchuk A, Dubuc M, Haigney M, Mazur A, McPherson CA, Mitchell LB, Natale A, Piccini JP, Raitt M, Rashtian MY, Schuger C, Winters S, Worley SJ, Ziv O, Moss AJ; RAID Trial Investigators.

J Am Coll Cardiol. 2018 Aug 7;72(6):636-645. doi: 10.1016/j.jacc.2018.04.086.

6.

Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF).

Silberberg A, Tan MK, Yan AT, Angaran P, Dorian P, Bucci C, Gregoire JC, Bell AD, Gladstone DJ, Green MS, Gross PL, Skanes A, Demchuk AM, Kerr CR, Mitchell LB, Cox JL, Talajic M, Essebag V, Heilbron B, Ramanathan K, Fournier C, Wheeler BH, Lin PJ, Berall M, Langer A, Goldin L, Goodman SG; FREEDOM AF and CONNECT AF Investigators.

Am J Cardiol. 2017 Aug 15;120(4):582-587. doi: 10.1016/j.amjcard.2017.05.027. Epub 2017 Jun 1.

PMID:
28666577
7.

A unique form of a brady-tachy syndrome.

Ilhan E, Quinn FR, Exner DV, Mitchell LB, Veenhuyzen GD.

Pacing Clin Electrophysiol. 2017 Jul;40(7):894-896. doi: 10.1111/pace.13120. Epub 2017 Jun 30. No abstract available.

PMID:
28543039
8.

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.

Macle L, Cairns J, Leblanc K, Tsang T, Skanes A, Cox JL, Healey JS, Bell A, Pilote L, Andrade JG, Mitchell LB, Atzema C, Gladstone D, Sharma M, Verma S, Connolly S, Dorian P, Parkash R, Talajic M, Nattel S, Verma A; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2016 Oct;32(10):1170-1185. doi: 10.1016/j.cjca.2016.07.591. Epub 2016 Sep 6. Review. Erratum in: Can J Cardiol. 2017 Apr;33(4):552-553.

PMID:
27609430
9.

Molecular Differentiation of the African Yellow Fever Vector Aedes bromeliae (Diptera: Culicidae) from Its Sympatric Non-vector Sister Species, Aedes lilii.

Bennett KL, Linton YM, Shija F, Kaddumukasa M, Djouaka R, Misinzo G, Lutwama J, Huang YM, Mitchell LB, Richards M, Tossou E, Walton C.

PLoS Negl Trop Dis. 2015 Dec 7;9(12):e0004250. doi: 10.1371/journal.pntd.0004250. eCollection 2015 Dec.

10.

The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients.

Angaran P, Dorian P, Tan MK, Kerr CR, Green MS, Gladstone DJ, Mitchell LB, Fournier C, Cox JL, Talajic M, Lin PJ, Langer A, Goldin L, Goodman SG.

Can J Cardiol. 2016 Mar;32(3):336-43. doi: 10.1016/j.cjca.2015.07.012. Epub 2015 Oct 15.

PMID:
26476851
11.

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines.

Macle L, Cairns JA, Andrade JG, Mitchell LB, Nattel S, Verma A; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2015 Oct;31(10):1207-18. doi: 10.1016/j.cjca.2015.06.005.

PMID:
26429352
12.

Sudden cardiac death.

Kuriachan VP, Sumner GL, Mitchell LB.

Curr Probl Cardiol. 2015 Apr;40(4):133-200. doi: 10.1016/j.cpcardiol.2015.01.002. Epub 2015 Feb 7. Review.

PMID:
25813838
13.

The new Canadian Cardiovascular Society algorithm for antithrombotic therapy of atrial fibrillation is appropriately based on current epidemiologic data.

Cairns JA, Healey JS, Macle L, Mitchell LB, Verma A; Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2015 Jan;31(1):20-3. doi: 10.1016/j.cjca.2014.11.021. Epub 2014 Nov 26. No abstract available.

PMID:
25547545
14.

2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation.

Verma A, Cairns JA, Mitchell LB, Macle L, Stiell IG, Gladstone D, McMurtry MS, Connolly S, Cox JL, Dorian P, Ivers N, Leblanc K, Nattel S, Healey JS; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2014 Oct;30(10):1114-30. doi: 10.1016/j.cjca.2014.08.001. Epub 2014 Aug 13. Erratum in: Can J Cardiol. 2014 Dec;30(12):1495. Can J Cardiol. 2015 Oct;31(10):1302.

PMID:
25262857
15.

Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.

Mitchell LB, Southern DA, Galbraith D, Ghali WA, Knudtson M, Wilton SB; APPROACH investigators.

Heart. 2014 Oct;100(19):1524-30. doi: 10.1136/heartjnl-2013-305303. Epub 2014 May 23.

PMID:
24860007
16.

Mosquitoes of eastern Amazonian Ecuador: biodiversity, bionomics and barcodes.

Linton YM, Pecor JE, Porter CH, Mitchell LB, Garzón-Moreno A, Foley DH, Pecor DB, Wilkerson RC.

Mem Inst Oswaldo Cruz. 2013;108 Suppl 1:100-9. doi: 10.1590/0074-0276130440.

18.

Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.

Skanes AC, Healey JS, Cairns JA, Dorian P, Gillis AM, McMurtry MS, Mitchell LB, Verma A, Nattel S; Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2012 Mar-Apr;28(2):125-36. doi: 10.1016/j.cjca.2012.01.021. Erratum in: Can J Cardiol. 2012 May;28(3):396.

PMID:
22433576
19.

Diagnostic pacing maneuvers for supraventricular tachycardias: part 2.

Veenhuyzen GD, Quinn FR, Wilton SB, Clegg R, Mitchell LB.

Pacing Clin Electrophysiol. 2012 Jun;35(6):757-69. doi: 10.1111/j.1540-8159.2012.03352.x. Epub 2012 Mar 4.

PMID:
22385228
20.

Diagnostic pacing maneuvers for supraventricular tachycardia: part 1.

Veenhuyzen GD, Quinn FR, Wilton SB, Clegg R, Mitchell LB.

Pacing Clin Electrophysiol. 2011 Jun;34(6):767-82. doi: 10.1111/j.1540-8159.2011.03076.x. Epub 2011 Mar 25. Review.

PMID:
21438892
21.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery.

Mitchell LB; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):91-7. doi: 10.1016/j.cjca.2010.11.005.

PMID:
21329866
22.

Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction.

Wilton SB, Fundytus A, Ghali WA, Veenhuyzen GD, Quinn FR, Mitchell LB, Hill MD, Faris P, Exner DV.

Am J Cardiol. 2010 Nov 1;106(9):1284-91. doi: 10.1016/j.amjcard.2010.06.053. Review.

PMID:
21029825
23.

Attenuated recovery of heart rate turbulence early after myocardial infarction identifies patients at high risk for fatal or near-fatal arrhythmic events.

Huikuri HV, Exner DV, Kavanagh KM, Aggarwal SG, Mitchell LB, Messier MD, Becker D, Sheldon RS, Bloch Thomsen PE; CARISMA and REFINE Investigators.

Heart Rhythm. 2010;7(2):229-35. doi: 10.1016/j.hrthm.2009.11.004. Epub 2009 Nov 10.

PMID:
20129299
24.

Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.

Kowey PR, Dorian P, Mitchell LB, Pratt CM, Roy D, Schwartz PJ, Sadowski J, Sobczyk D, Bochenek A, Toft E; Atrial Arrhythmia Conversion Trial Investigators.

Circ Arrhythm Electrophysiol. 2009 Dec;2(6):652-9. doi: 10.1161/CIRCEP.109.870204.

PMID:
19948506
25.

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.

Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, Bardy GH.

Circulation. 2009 Dec 1;120(22):2170-6. doi: 10.1161/CIRCULATIONAHA.109.853689. Epub 2009 Nov 16. Erratum in: Circulation. 2010 Feb 16;121(6):e39.

26.

Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale.

Dorian P, Guerra PG, Kerr CR, O'Donnell SS, Crystal E, Gillis AM, Mitchell LB, Roy D, Skanes AC, Rose MS, Wyse DG.

Circ Arrhythm Electrophysiol. 2009 Jun;2(3):218-24. doi: 10.1161/CIRCEP.108.812347. Epub 2009 Mar 31.

PMID:
19808471
27.

Canadian Registry of ICD Implant Testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testing.

Healey JS, Dorian P, Mitchell LB, Talajic M, Philippon F, Simpson C, Yee R, Morillo CA, Lamy A, Basta M, Birnie DH, Wang X, Nair GM, Crystal E, Kerr CR, Connolly SJ; CREDIT Investigators.

J Cardiovasc Electrophysiol. 2010 Feb;21(2):177-82. doi: 10.1111/j.1540-8167.2009.01616.x. Epub 2009 Oct 5.

PMID:
19804544
28.

Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?

Mitchell LB.

J Am Coll Cardiol. 2009 Aug 11;54(7):616-7. doi: 10.1016/j.jacc.2009.05.020. No abstract available.

29.

Is pulmonary vein isolation required for paroxysmal atrial fibrillation? Perhaps the answer depends on the question.

Kuriachan V, Veenhuyzen GD, Quinn FR, Mitchell LB.

J Cardiovasc Electrophysiol. 2008 Dec;19(12):1329-31. doi: 10.1111/j.1540-8167.2008.01337.x. Epub 2008 Oct 22. No abstract available.

PMID:
19017347
30.

Overdrive ventricular pacing to clarify the diagnosis of a left bundle branch block morphology tachycardia.

Quinn FR, Mitchell LB, Mardell A, Veenhuyzen GD.

Heart Rhythm. 2008 Oct;5(10):1479-81. doi: 10.1016/j.hrthm.2007.12.016. Epub 2007 Dec 23. No abstract available.

PMID:
18672404
31.

Single diagnostic pacing maneuver for supraventricular tachycardia.

Veenhuyzen GD, Coverett K, Quinn FR, Sapp JL, Gillis AM, Sheldon R, Exner DV, Mitchell LB.

Heart Rhythm. 2008 Aug;5(8):1152-8. doi: 10.1016/j.hrthm.2008.04.010. Epub 2008 Apr 15.

PMID:
18554986
32.

Role of drug therapy for sustained ventricular tachyarrhythmias.

Mitchell LB.

Cardiol Clin. 2008 Aug;26(3):405-18, vi. doi: 10.1016/j.ccl.2008.03.004. Review.

PMID:
18538187
33.

Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation.

Gillis AM, Morck M, Exner DV, Soo A, Rose MS, Sheldon RS, Duff HJ, Kavanagh KM, Mitchell LB, Wyse DG.

Eur Heart J. 2008 Aug;29(15):1873-80. doi: 10.1093/eurheartj/ehn192. Epub 2008 May 13.

PMID:
18477727
34.

Noninvasive risk assessment early after a myocardial infarction the REFINE study.

Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG, Noullett C, Van Schaik A, Mitchell RT, Shibata MA, Gulamhussein S, McMeekin J, Tymchak W, Schnell G, Gillis AM, Sheldon RS, Fick GH, Duff HJ; REFINE Investigators.

J Am Coll Cardiol. 2007 Dec 11;50(24):2275-84. Epub 2007 Nov 26.

35.

Distinguishing focal from macroreentrant atrial tachycardias: has this job just become easier?

Veenhuyzen GD, Mitchell LB.

J Cardiovasc Electrophysiol. 2008 Feb;19(2):148-9. Epub 2007 Nov 21. No abstract available.

PMID:
18031509
36.

Entrainment mapping of a concealed nodoventricular accessory pathway in a man with complete heart block and tachycardia-induced cardiomyopathy.

Quinn FR, Mitchell LB, Mardell AP, Dal Disler RN, Veenhuyzen GD.

J Cardiovasc Electrophysiol. 2008 Jan;19(1):90-4. Epub 2007 Jul 30.

PMID:
17666058
39.

Prophylactic therapy to prevent atrial arrhythmia after cardiac surgery.

Mitchell LB.

Curr Opin Cardiol. 2007 Jan;22(1):18-24. Review.

PMID:
17143040
40.

Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis.

Bagshaw SM, Galbraith PD, Mitchell LB, Sauve R, Exner DV, Ghali WA.

Ann Thorac Surg. 2006 Nov;82(5):1927-37. Review.

PMID:
17062287
41.

Atrial fibrillation: challenges and opportunities.

Hersi A, Mitchell LB, Wyse DG.

Can J Cardiol. 2006 Aug;22 Suppl C:21C-26C.

42.

A tale of two post pacing intervals.

Veenhuyzen GD, Stuglin C, Zimola KG, Mitchell LB.

J Cardiovasc Electrophysiol. 2006 Jun;17(6):687-9. No abstract available.

PMID:
16836725
43.

Universal access -- but when? Treating the right patient at the right time: access to electrophysiology services in Canada.

Simpson CS, Healey JS, Philippon F, Dorian P, Mitchell LB, Sapp JL Jr, O'Neill BJ, Sholdice MM, Green MS, Sterns LD, Yee R; Canadian Cardiovascular Society Access to Care Working Group; Canadian Heart Rhythm Society.

Can J Cardiol. 2006 Jul;22(9):741-6. Review.

44.

A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale.

Dorian P, Cvitkovic SS, Kerr CR, Crystal E, Gillis AM, Guerra PG, Mitchell LB, Roy D, Skanes AC, Wyse DG.

Can J Cardiol. 2006 Apr;22(5):383-6.

45.

Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.

Mitchell LB, Exner DV, Wyse DG, Connolly CJ, Prystai GD, Bayes AJ, Kidd WT, Kieser T, Burgess JJ, Ferland A, MacAdams CL, Maitland A.

JAMA. 2005 Dec 28;294(24):3093-100.

PMID:
16380589
46.

Similarities and differences between atrial flutter and atrial fibrillation.

Simpson CS, Mitchell LB, Klein GJ.

Can J Cardiol. 2005 Sep;21 Suppl B:67B-70B.

PMID:
16239991
47.

Atrial fibrillation following cardiac surgery.

Mitchell LB, Crystal E, Heilbron B, Pagé P.

Can J Cardiol. 2005 Sep;21 Suppl B:45B-50B.

PMID:
16239988
48.

Clinical evaluation of the Sorin Synthesis oxygenator with integrated arterial filter.

Myers GJ, Gardiner K, Ditmore SN, Swyer WJ, Squires C, Johnstone DR, Power CV, Mitchell LB, Ditmore JE, Cook B.

J Extra Corpor Technol. 2005 Jun;37(2):201-6.

49.

Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study.

Olshansky B, Heller EN, Mitchell LB, Chandler M, Slater W, Green M, Brodsky M, Barrell P, Greene HL.

J Am Coll Cardiol. 2005 Jun 21;45(12):2026-33.

50.

The prevention of sudden cardiac death: the role of the automated external defibrillator.

Mitchell LB.

Can J Cardiol. 2005 May;21 Suppl A:41A-46A. Review.

PMID:
15953944

Supplemental Content

Loading ...
Support Center